MedMira Inc. (TSXV:MIR)
0.120
0.00 (0.00%)
Feb 21, 2025, 3:53 PM EST
MedMira Revenue
MedMira had revenue of 61.72K CAD in the quarter ending October 31, 2024, a decrease of -47.63%. This brings the company's revenue in the last twelve months to 356.43K, down -17.04% year-over-year. In the fiscal year ending July 31, 2024, MedMira had annual revenue of 412.57K, down -4.61%.
Revenue (ttm)
356.43K
Revenue Growth
-17.04%
P/S Ratio
236.22
Revenue / Employee
6.85K
Employees
52
Market Cap
84.21M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 412.57K | -19.96K | -4.61% |
Jul 31, 2023 | 432.53K | -519.60K | -54.57% |
Jul 31, 2022 | 952.13K | -1.19M | -55.60% |
Jul 31, 2021 | 2.14M | 1.23M | 133.33% |
Jul 31, 2020 | 919.07K | 391.63K | 74.25% |
Jul 31, 2019 | Pro | Pro | Pro |
Jul 31, 2018 | Pro | Pro | Pro |
Jul 31, 2017 | Pro | Pro | Pro |
Jul 31, 2016 | Pro | Pro | Pro |
Jul 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.51B |
WELL Health Technologies | 957.69M |
dentalcorp Holdings | 1.51B |
Curaleaf Holdings | 1.83B |
Sienna Senior Living | 893.16M |
Trulieve Cannabis | 1.58B |
Cronos Group | 150.26M |
Extendicare | 1.42B |
MedMira News
- 4 weeks ago - MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications - Accesswire
- 4 weeks ago - MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications - Accesswire
- 5 weeks ago - MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use - Accesswire
- 5 weeks ago - MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use - Accesswire
- 6 weeks ago - MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - Accesswire
- 7 weeks ago - MedMira Reports First Quarter Results FY2025 - Accesswire
- 2 months ago - MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV - Accesswire
- 3 months ago - MedMira Reports FY2024 Fourth Quarter and Year End Financial Results - Accesswire